Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page
- CheckyesterdayChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check8 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe website has been updated with new entries for January 2025, including a revision to v2.14.1, while previous updates from December 2024 have been removed.SummaryDifference0.8%
- Check30 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check59 days agoChange DetectedThe website has updated the listing for BioBehavioral Research of Austin PC, moving from revision v2.13.2 to v2.13.3, with the latest update posted on December 5, 2024.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated its contact details section for the study, now providing clearer information on who to contact and where the study is taking place, along with a new revision update.SummaryDifference3%
Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.